ROIVANT SCIENCES LTD. reported 1 transaction at ARBUTUS BIOPHARMA CORP
Review the transaction codes below to understand the nature of each event.
Filed: 10/6/2026ACC: 0001140361-26-038692
10% Owner
Since Oct 2021
-8.97M
Net shares
Net seller
$44.84M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.97M disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−8.97M
Price / share
$5.00
Trade value
$44.84M
% of position
23.1%
10/1/2026
38.85M→29.88M
Total
Net shares
−8.97M
Net value
-$44.84M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 10/1/2026 | D · Disposition | −8.97M | $5.00 | $44.84M | 23.1% | 38.85M | 29.88M |
| Total | −8.97M | -$44.84M | ||||||
Derivative Transactions0
No derivative transactions reported